Nerissa Kreher - 28 Oct 2021 Form 3 Insider Report for Entrada Therapeutics, Inc. (TRDA)

Role
Chief Medical Officer
Signature
/s/ Jared Cohen, as Attorney-in-fact
Issuer symbol
TRDA
Transactions as of
28 Oct 2021
Net transactions value
$0
Form type
3
Filing time
28 Oct 2021, 21:00:26 UTC
Previous filing
14 Jul 2021
Next filing
29 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TRDA Stock Option (Right to Buy) 28 Oct 2021 Common Stock 147,922 $2.10 Direct F1
holding TRDA Stock Option (Right to Buy) 28 Oct 2021 Common Stock 63,826 $8.47 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to this option shall vest and become exercisable on December 7, 2021, with the remaining 75% vesting in 36 equal monthly installments thereafter.
F2 25% of the shares subject to this option shall vest and become exercisable on March 30, 2022, with the remaining 75% vesting in 36 equal monthly installments thereafter.

Remarks:

Exhibit 24 - Power of Attorney